Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism – A pilot study
The study sciencedirect.com/science/a... is important since it invalidates current guidance on diagnosis of hypothyroidism (including the recent NICE guidance) and uncovers a novel form of hypothyroidism which cannot be detected by blood tests.
A prospective study, it investigated fT3, fT4 in serum and in CSF in untreated newly diagnosed patients with mild primary hypothyroidism compared to healthy matched controls. The patients had mild primary hypothyroidism which is usually wrongly described as ‘subclinical hypothyroidism’. The patients had a median TSH of 4.96 and controls had a median TSH of 1.6 (0.4 – 4.0 mIE/L). There was no difference in fT3 between patients and controls. Patients had a median fT4 of 11.7 compared to 13.5 for controls (11-22 pmol/l). A TSH greater than 4.0 was considered hypothyroid provided the patients had a Zulewski score > 5. Zulewski devised a scoring system for evaluating signs and symptoms of hypothyroidism academic.oup.com/jcem/artic... .
The patients in this study were diagnosed if they had a mildly elevated TSH with signs and symptoms of hypothyroidism. Patients had lower general health Likert scores than controls. This could be due to selection bias as the patients presented with recent onset of fatigue, hypersomnia or lethargy.
On AVERAGE the patients’ CSF fT3, CSF fT4, CSF/serum fT3 ratio and CSF/serum fT4 ratio did not differ from controls. However, patients (but not controls) with lower CSF/serum fT4 ratios had lower Health Likert scores and higher MADRS depression scores. This highlights the danger of using averages in thyroid research.
TSH responds to serum fT3, fT4 levels and stimulates thyroidal secretion and deiodinase (T4 to T3 conversion). Symptomatic patients had lower CSF/serum fT4 ratios. This study finds an association between a lower ratio and symptoms - an association not causation. It’s possible that patients’ impaired health or depression caused the lower CSF/serum fT4 ratio. This is unlikely as both non-thyroidal illness and depression present with a lowered TSH with reduced bioactivity and results in ‘low T3 syndrome’.
It is quite possible that the mildly elevated TSH was an irrelevant factor, that the impaired CSF/serum fT4 ratio has nothing to do with thyroid failure. For example, some endocrine disrupting chemicals such as PBDEs have a strong affinity for transthyretin (TTR) which is the major T4 transport protein in the CSF. This form of hypothyroidism may have nothing to do with the thyroid. It would be useful to repeat the experiment when the patients have had their TSH normalised, to see if their CSF/serum fT4 ratio changes. A second trial in symptomatic patients with normal thyroid profiles should also be undertaken. Finally, the relationship between thyroid hormone in the CSF and the brain is poorly understood. Whilst CSF hormone levels are probably indicative of brain levels, they are unlikely to be an accurate marker.
This study is of major importance because: -
1. The study proves that patients can be hypothyroid with a mildly elevated TSH and normal fT3, fT4. This invalidates current guidance on the diagnosis and treatment of hypothyroidism.
2. The study supports the concept that the hypothalamic pituitary thyroid axis responds to serum hormone levels rather than central (brain/CSF) hormone levels. The CSF/serum fT4 ratios were lower and the patients had symptoms originating from the brain indicating that brain hypothyroidism may not be reflected in serum hormone levels.
3. The study shows that even mild hormone deficiencies cause substantial symptoms. Subnormal TSH secretion presents with lower serum fT3 AND fT4 levels. This study supports my hypothesis that low normal fT3 AND fT4 causes a devastating form of hypothyroidism presenting with ‘normal’ TFTs.